Nevro Corp. buy Royal Bank of Canada
Start price
31.05.23
/
50%
€25.40
Target price
31.05.24
€37.44
Performance (%)
-66.14%
End price
01.06.24
€8.60
Summary
This prediction ended on 01.06.24 with a price of €8.60. The BUY prediction by Royal_Bank_of_Canada for Nevro Corp. performed very badly with a performance of -66.14%. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Nevro Corp. | - | - | - | - |
| iShares Core DAX® | -1,28 % | 4,21 % | 7,08 % | 64,25 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % | 26,18 % | 84,97 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % | 44,32 % | 79,25 % |
| iShares S&P 500 | -2,31 % | -0,10 % | 20,82 % | 68,08 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Nevro Corp. diskutieren
Nevro Corp. (NYSE: NVRO) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $40.00 price target on the stock.
Ratings data for NVRO provided by MarketBeat
In the thread Trading Nevro Corp.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten